MDCX
MEDICUS PHARMA LTD.Marquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors re-entered | Q3 2025(8Q snapshot) | 3Q | $0.00 | — | — |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Two Sigma Investments | Q1 2026 | Q2 2026 | — | +0% |
| Third Point 3× in & out | Q3 2021 | Q2 2022 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Medicus Pharma Ltd.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 4, 2026 — the most recent Form 4 on file — not from today.
- Form 40000950142-26-001643Jun 4, 2026
- Form 40000950142-26-001642Jun 4, 2026
- Form 40000950142-26-001641Jun 4, 2026
- Form 40000950142-26-001640Jun 4, 2026
- Form 40000950142-26-001639Jun 4, 2026
- Form 40000950142-26-001638Jun 4, 2026
- Form 40000950142-26-001637Jun 4, 2026
- Form 40000950142-26-001636Jun 4, 2026
- Form 40000950142-26-001635Jun 4, 2026
- Form 40000950142-26-001634Jun 4, 2026
- Form 40000950142-26-001633Jun 4, 2026
- Form 40000950142-26-001632Jun 4, 2026
- Form 40000950142-26-001631Jun 4, 2026
- Form 40000950142-26-001033Apr 1, 2026
- Form 40000950142-26-001032Apr 1, 2026
Fundamentals
XBRL · MEDICUS PHARMA LTD.Annual figures sourced directly from MEDICUS PHARMA LTD.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Medicus Pharma Ltd. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KJun 4, 2026
- 8-KFORM 8-KMay 27, 2026
- 10-QFORM 10-QMay 14, 2026
- DEF 14AFORM DEF 14AMay 4, 2026
- 10-K/AFORM 10-K/AApr 29, 2026
- 8-KFORM 8-KApr 24, 2026
- 10-KFORM 10-KMar 25, 2026
- 8-KFORM 8-KMar 6, 2026
- S-3FORM S-3Jan 30, 2026
- 8-KFORM 8-KDec 30, 2025
- S-3FORM S-3Dec 30, 2025
- 8-KFORM 8-KDec 8, 2025
- 8-KFORM 8-KDec 1, 2025
- S-1FORM S-1Nov 19, 2025
- 8-KFORM 8-KNov 14, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q2 2026 | open | $0.00 | — | +0% |
| Two Sigma Investments | Q1 2026 | Q2 2026 | $0.00 | — | +0% |
| Citadel Advisors | Q3 2025 | Q4 2025 | $0.00 | — | +0% |
| Third Point | Q3 2021 | Q1 2022 | $0.00 | — | +0% |
| Third Point | Q3 2021 | Q2 2022 | $0.00 | — | +0% |
| Third Point | Q2 2021 | Q3 2021 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.